These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 12133384

  • 1. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P, Wang H, Zhou H, Zhong H, Li F, Huang X, Zhong H, Fu T.
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [Abstract] [Full Text] [Related]

  • 2. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M, Liu Q, Min H, Du H, Hu T.
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [Abstract] [Full Text] [Related]

  • 3. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P, Sun M.
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A.
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vogt-koyanagi-harada syndrome.
    Fang W, Yang P.
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
    Fang W, Zhou H, Yang P, Huang X, Wang L, Kijlstra A.
    Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
    Paredes I, Ahmed M, Foster CS.
    Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.